Hong Qin Selected Research

Fibrosis (Cirrhosis)

11/2020	Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial.
1/2020	Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis.
11/2014	Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Qin Research Topics

Disease

68	Neoplasms (Cancer) 12/2023 - 08/2002
13	Lymphoma (Lymphomas) 12/2023 - 06/2006
11	Obesity 12/2023 - 01/2018
9	Infections 12/2022 - 03/2012
8	Neoplasm Metastasis (Metastasis) 10/2023 - 08/2016
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 05/2006
7	Neuroblastoma 11/2023 - 01/2019
6	Colitis 04/2024 - 12/2008
6	Insulin Resistance 12/2023 - 05/2009
6	Body Weight (Weight, Body) 01/2023 - 01/2019
6	Inflammation (Inflammations) 01/2022 - 11/2009
5	Thrombosis (Thrombus) 10/2023 - 08/2019
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 08/2006
4	Leukemia 12/2023 - 01/2018
4	Hepatitis B 12/2022 - 07/2014
4	Breast Neoplasms (Breast Cancer) 12/2021 - 08/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017 - 08/2009
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2011 - 05/2006
3	Pathologic Constriction (Stenosis) 12/2023 - 02/2022
3	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2017
3	Hepatoblastoma 09/2023 - 08/2009
3	COVID-19 01/2023 - 01/2020
3	Liver Diseases (Liver Disease) 12/2022 - 01/2015
3	Heart Failure 01/2022 - 10/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2016
3	Fibrosis (Cirrhosis) 11/2020 - 11/2014
3	Ulcerative Colitis 07/2012 - 12/2008
3	Poisoning 10/2010 - 12/2007
2	Hyperplasia 12/2023 - 05/2020
2	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 01/2017
2	Adrenocortical Carcinoma 10/2023 - 08/2009
2	Rupture 01/2023 - 03/2020
2	Hepatitis 01/2023 - 01/2021
2	Biliary Atresia 12/2022 - 11/2022
2	Lung Neoplasms (Lung Cancer) 07/2022 - 02/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2020
2	Liver Neoplasms (Liver Cancer) 01/2022 - 08/2016
2	Nasopharyngeal Carcinoma 01/2021 - 05/2015
2	Chronic Hepatitis C 11/2020 - 08/2019

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 12/2023 - 05/2006
12	Therapeutic UsesIBA 04/2024 - 12/2008
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2003
10	VaccinesIBA 05/2023 - 05/2006
8	sesamolIBA 12/2023 - 01/2019
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2006
6	LipidsIBA 12/2022 - 01/2019
6	Chimeric Antigen ReceptorsIBA 12/2022 - 01/2017
5	DNA VaccinesIBA 07/2014 - 07/2006
5	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 06/2006
4	EnzymesIBA 12/2021 - 09/2014
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 09/2007
4	Antiviral Agents (Antivirals)IBA 01/2020 - 03/2012
4	ChemokinesIBA 01/2014 - 07/2006
3	CytokinesIBA 04/2024 - 12/2008
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2023 - 01/2022
3	LignansIBA 01/2023 - 01/2021
3	Sesame Oil (Oil, Sesame)IBA 01/2023 - 01/2019
3	B-Cell Activation Factor ReceptorIBA 01/2023 - 01/2018
3	Insulin (Novolin)FDA Link 01/2023 - 10/2020
3	Long Noncoding RNAIBA 12/2022 - 08/2016
3	Messenger RNA (mRNA)IBA 12/2022 - 07/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 09/2014
3	punicalaginIBA 01/2021 - 12/2019
3	EpitopesIBA 05/2013 - 05/2006
3	SurvivinIBA 08/2009 - 11/2007
3	ConnexinsIBA 12/2006 - 08/2002
3	Connexin 43 (Connexin43)IBA 01/2006 - 08/2002
2	Dextrans (Dextran)FDA Link 04/2024 - 01/2022
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2024 - 01/2022
2	Prealbumin (Transthyretin)IBA 12/2023 - 01/2022
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 12/2014
2	Hormones (Hormone)IBA 10/2023 - 01/2023
2	Concanavalin AIBA 01/2023 - 01/2021
2	Dextran SulfateIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2023 - 12/2022
2	Phosphates (Orthophosphate)IBA 01/2023 - 01/2021
2	6-methyladenineIBA 12/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2021
2	NucleotidesIBA 12/2022 - 01/2020
2	IronIBA 07/2022 - 01/2022
2	Sirtuin 1IBA 02/2022 - 06/2011
2	Palmitic Acid (Hexadecanoic Acid)IBA 02/2022 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	LigandsIBA 12/2021 - 09/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2009
2	Circular RNAIBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
2	AntioxidantsIBA 01/2021 - 01/2020
2	InterferonsIBA 11/2020 - 11/2014
2	SofosbuvirIBA 11/2020 - 01/2020
2	CD19 AntigensIBA 10/2020 - 01/2019

Therapy/Procedure

21	Therapeutics 12/2023 - 01/2014
19	Drug Therapy (Chemotherapy) 10/2023 - 06/2006
12	Liver Transplantation 01/2023 - 08/2019
12	Immunotherapy 10/2022 - 09/2007
3	Transplantation 12/2020 - 01/2015
2	Pancreatectomy 01/2021 - 09/2020